South Korea to Sharply Increase R&D Support for New Drugs in 2008 (South Korea)
This article was originally published in PharmAsia News
In an attempt to expand its reach in the global pharmaceutical market, South Korea has announced it will significantly increase financial support for drug discovery and development. In 2008, the Ministry of Science and Technology will boost the country's research and development budget by 52 percent to $100.3 million. The government hopes by pouring this amount of money into pharmaceuticals, South Korea will be able to produce one new drug every year until 2016. (Click here for more - May Require Paid Subscription
You may also be interested in...
A package of health proposals intended to build up the EU’s resilience to health threats while strengthening the competitiveness of Europe’s pharmaceutical industry and ensuring access to affordable drugs takes a major step through the legislative process this week.
Hikma has pushed back against a further attempt by Amarin to counter its US generic version of Vascepa, this time via a fresh lawsuit claiming that the generic induces infringement of patents protecting cardiovascular indications for which the brand is approved but which are carved out of the generic label.
The European Medicines Agency will continue working over the Christmas period so that it can complete its assessment of the newly filed marketing applications for BioNTech/Pfizer’s and Moderna’s COVID-19 vaccines as soon possible.